Reversible reprogramming regenerates cardiac tissue after a heart attack
Endpoints News - 23-Sep-2021Possibility of regeneration: A boon to the broad rejuvenation field
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Professor at Baylor College of Medicine
Principal Investigator directing laboratories at Baylor College of Medicine and Texas Heart Institute Co-founder of Yap Therapeutics a biotech company focused on treating heart failure through endogenous tissue renewal. His professional Interests include Cell and Developmental Biology, Molecular Biology and Genetics, Human Disease, Cardiovascular Sciences.
Visit website: https://www.bcm.edu/people-search/james-martin-26213
See alsoDetails last updated 25-Sep-2021
Possibility of regeneration: A boon to the broad rejuvenation field